IEM Weekly Newsletter
October 25, 2022
View this email in your browser.
In This Newsletter


Victor Nizet Elected to National Academy of Medicine

Victor Nizet, MD, Distinguished Professor of Pediatrics at University of California San Diego School of Medicine and Pharmacy at Skaggs School of Pharmacy and Pharmaceutical Sciences, has been elected to the National Academy of Medicine. Congratulations Dr. Nizet!
Read More


IEEE Brain Discovery Neurotechnology Workshop –
Brain, Mind, and Body: Cognitive Neuroengineering for Health and Wellness

Thursday, November 10 8:00AM - Friday, November 11 5:00 PM PST
Register by: November 7, 2022

This is the third in a series of symposia and workshops that brings together researchers and practitioners across academia, industry and the clinical profession to catalyze advances in unobtrusive neurotechnology and cognitive neuroscience towards more effective and sustainable healthcare through holistic integration of engineering and medicine with a focus on minimally invasive strategies, including neurofeedback and electroceuticals, that harness harmony between brain, mind, and body.

The program calls for contributed interactive poster presentations and live demonstrations of neurotechnologies. The hybrid event is open to the public, and registration is free for both in-person and virtual attendance.  Prize awards are conferred upon the best poster and demonstration presenters among student participants.
Learn More
MARC Southern California RheumTalk Seminar Series

Thursdays at 12PM PST
Zoom Link:

Thursday October 27, 2022 12PM-1PM
Non-articular comorbidities of rheumatoid arthritis
​​Jon Giles, MD, Associate Professor of Medicine, Division of Rheumatology

Full MARC Seminar Schedule
Fall 2022 Seminar Series
Sponsored by The Department of Bioengineering and the Institute of Engineering in Medicine (IEM).
Fridays, 2-3PM PST - FUNG Auditorium/PFBH
Faculty Host: Brian Aguado, Ph.D.

Friday, October 28, 2022
Michelle LaPlaca, Ph.D.
Modeling Heterogeneity in Preclinical Traumatic Brain Injury Studies

Click here for more information and a list of upcoming seminars


AIM Research Grant Opportunity
AIM is designed to accelerate the translation of UC San Diego technologies to market and support the formation and growth of startups in the UC San Diego ecosystem. The Office of Innovation and Commercialization is working with Premier Innovation Partners EMD-Serono, Merck KGaA Darmstadt, and Takeda to provide mentoring, resources, funding, and access to partners and investors to advance ideas from UC San Diego labs through feasibility projects and validation prototypes, and ultimately to scale. 

Internal Submission Deadline: Friday, November 4, 2022

Click here to apply
Visit their webpage to learn more
Connect With Us!

Want to follow IEM for more news and updates?

Check out our social media! 
We're on Twitter, LinkedIn, and Instagram. Never miss an update from IEM and get news on the latest seminars, awards, and stories from our members and centers.

Twitter: @ucsd_iem
LinkedIn: UC San Diego IEM
In an effort to promote all updates and the success of our various Centers, IEM would like to hear your stories. Submit any news, updates, stories regarding your center or research and we will publicize the content across all IEM media outlets!

Click the button below to submit a Google Form and let us know about any opportunities or information you have to share. We will take care of the rest!
Submit an Update
Learn more about IEM and connect with our Research Centers:
Biomaterials and Tissue Engineering Center | Center for Musculoskeletal Research
Center for Advanced Neurological Engineering | Whitaker Center for Biomedical Engineering | Cardiac Biomedical Science and Engineering Center | Center for Medical Device Engineering and Biomechanics | Center for Engineering in Cancer | Center for Mobile-health Systems and Applications | Infectious Disease Engineering Advances

Contact Us:
Department Email:

Want to change how you receive these emails?
You can
update your preferences or unsubscribe from this list.